6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+56.67%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$992M
AUM Growth
+$992M
(+54%)
Cap. Flow
-$22.4M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
57.51%
Holding
162
New
13
Increased
20
Reduced
28
Closed
20
Top Buys
| 1 |
IAC Inc
IAC
|
$97.8M |
| 2 |
PG&E
PCG
|
$28.2M |
| 3 |
AFMD
Affimed
AFMD
|
$9.92M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$8.47M |
| 5 |
ARYBU
ARYA Sciences Acquisition Corp II Unit
ARYBU
|
$8.12M |
Top Sells
| 1 |
Wayfair
W
|
$38.5M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
$35.1M |
| 3 |
Larimar Therapeutics
LRMR
|
$31M |
| 4 |
DuPont de Nemours
DD
|
$18.6M |
| 5 |
Angi Inc
ANGI
|
$17.2M |
Sector Composition
| 1 | Communication Services | 25.03% |
| 2 | Consumer Discretionary | 24.32% |
| 3 | Healthcare | 22.42% |
| 4 | Financials | 6.92% |
| 5 | Consumer Staples | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
IAC Inc
IAC
$2.94B
| $166M | 13.28% | 513,050 +302,500 | +144% | +$97.8M |
|
2
Carvana
CVNA
$51.4B
| $165M | 13.21% | 1,373,423 -90,000 | -6% | -$10.8M |
|
3
Cardlytics
CDLX
$54.3M
| $59.9M | 4.8% | 856,606 -10,000 | -1% | -$700K |
|
4
Amazon
AMZN
$2.44T
| $33.1M | 2.65% | 12,000 | – | – |
|
5
Capital One
COF
$145B
| $30.8M | 2.46% | 491,617 -64,200 | -12% | -$4.02M |
|
|
6
PG&E
PCG
$33.6B
| $28.2M | 2.26% | 3,183,216 +3,183,116 | +3,183,116% | +$28.2M |
|
7
Diageo
DEO
$62.1B
| $25.5M | 2.04% | 190,000 +15,000 | +9% | +$2.02M |
|
8
uniQure
QURE
$896M
| $21.6M | 1.73% | 480,000 -10,000 | -2% | -$451K |
|
|
EIGR
9
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $20.7M | 1.66% | 2,156,839 +116,839 | +6% | +$1.12M |
|
10
Adient
ADNT
$2.01B
| $19.8M | 1.58% | 1,203,588 -50,000 | -4% | -$821K |
|
11
Altria Group
MO
$113B
| $17.8M | 1.43% | 453,860 -70,000 | -13% | -$2.75M |
|
12
Enova International
ENVA
$3.03B
| $17.1M | 1.37% | 1,148,058 +50,119 | +5% | +$745K |
|
|
AFMD
13
DELISTED
Affimed
AFMD
| $16.8M | 1.35% | 3,650,000 +2,150,000 | +143% | +$9.92M |
|
14
Immatics
IMTX
$619M
| $16.5M | 1.32% | 1,050,000 +50,000 | +5% | +$787K |
|
15
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.6M | 1.24% | 105,000 -65,000 | -38% | -$9.63M |
|
|
B
16
Barrick Mining Corporation
B
$45.4B
| $15.1M | 1.21% | 561,477 +50,000 | +10% | +$1.35M |
|
17
Syndax Pharmaceuticals
SNDX
$1.41B
| $15.1M | 1.21% | 1,016,371 +83,333 | +9% | +$1.23M |
|
18
Ardelyx
ARDX
$1.53B
| $14.9M | 1.19% | 2,154,184 | – | – |
|
|
19
Angi Inc
ANGI
$786M
| $12.8M | 1.02% | 1,049,673 -1,412,500 | -57% | -$17.2M |
|
|
KG
20
Kestrel Group, Ltd.
KG
$209M
| $9.77M | 0.78% | 7,876,964 | – | – |
|
21
VYNE Therapeutics
VYNE
$8.16M
| $9.6M | 0.77% | 5,550,208 +3,552,597 | +178% | +$6.15M |
|
22
Fennec Pharmaceuticals
FENC
$247M
| $9.27M | 0.74% | 1,110,000 +160,000 | +17% | +$1.34M |
|
23
Ventas
VTR
$30.9B
| $9.16M | 0.73% | 250,000 +25,000 | +11% | +$916K |
|
|
PRVB
24
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $8.47M | 0.68% | +600,000 | New | +$8.47M |
|
|
ROCC
25
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $8.43M | 0.67% | 884,603 -217,703 | -20% | -$2.07M |
|